Karina Vila-Rivera

Featured in: Favicon

onlinelibrary.wiley.com

Articles

Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial

Jun 24, 2024 | acrjournals.onlinelibrary.wiley.com | Joan T Merrill |Yoshiya Tanaka |David D'Cruz |Karina Vila-Rivera

Supporting Information Filename Description art42926-sup-0001-Disclosureform.pdfPDF document, 478.5 KB Disclosure Form art42926-sup-0002-Supinfo.pdfPDF document, 3.5 MB Appendix S1: Supporting Information

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →